Fig. 3From: Therapeutic efficacy of α-radioimmunotherapy with different activity levels of the 213Bi-labeled monoclonal antibody MX35 in an ovarian cancer modelPlatelet counts measured in the blood samples taken from the tail vein 6 and 14 days after treatment. Each group consisted of five animalsBack to article page